Biocompatibility and osteogenicity of degradable Ca-deficient hydroxyapatite scaffolds from calcium phosphate cement for bone tissue engineering

Acta Biomaterialia
Han GuoChangsheng Liu

Abstract

Ca-deficient hydroxyapatite (CDHA) porous scaffolds were successfully fabricated from calcium phosphate cement (CPC) by a particle-leaching method. The morphology, porosity and mechanical strength as well as degradation of the scaffolds were characterized. The results showed that the CDHA scaffolds with a porosity of 81% showed open macropores with pore sizes of 400-500mum. Thirty-six per cent of these CDHA scaffolds were degraded after 12 weeks in Tris-HCl solution. Mesenchymal stem cells (MSCs) were cultured, expanded and seeded on the scaffolds, and the proliferation and differentiation of MSCs into osteoblastic phenotype were determined using MTT assay, alkaline phosphatase activity and scanning electron microscopy. The results revealed that the CDHA scaffolds were biocompatible and had no negative effects on the MSCs in vitro. The in vivo biocompatibility and osteogenicity of the scaffolds were investigated. Both CDHA scaffolds and MSC/scaffold constructs were implanted in rabbit mandibles and studied histologically. The results showed that CDHA scaffolds exhibited good biocompatibility and osteoconductivity. Moreover, the introduction of MSCs into the scaffolds dramatically enhanced the efficiency of new bone formation, e...Continue Reading

Citations

Jan 25, 2011·Journal of Materials Science. Materials in Medicine·Jingxiong LuChangsheng Liu
May 10, 2011·Journal of Materials Science. Materials in Medicine·Jie WeiShicheng Wei
Feb 26, 2010·Journal of the Royal Society, Interface·Junfeng JiaChangsheng Liu
Mar 30, 2012·International Journal of Nanomedicine·Hong LiYonggang Yan
Jul 20, 2013·Tissue Engineering. Part B, Reviews·Nattharee ChanchareonsookJohn A Jansen
Jul 4, 2013·Annals of Biomedical Engineering·Esther J LeeAntonios G Mikos
Nov 16, 2013·Acta Biomaterialia·Jingtao ZhangJean-Michel Bouler
Dec 9, 2009·Biomaterials·Sergey V Dorozhkin
Apr 8, 2015·Journal of Biomedical Materials Research. Part a·Chang-Chin WuKai-Chiang Yang
Jan 7, 2011·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Andrea EwaldUwe Gbureck
May 21, 2011·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Lei XiongJiabo Jin
Apr 12, 2012·Journal of Biomedical Materials Research. Part a·Elahe MasaeliHossein Baharvand
Feb 27, 2010·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Xianchun ChenGuangfu Yin
Mar 29, 2014·Journal of Biomedical Materials Research. Part a·Duong T Nguyen, Karen J L Burg
Jul 5, 2011·Journal of Zhejiang University. Science. B·Rui-na YangHong Bu
Apr 10, 2015·Journal of the Mechanical Behavior of Biomedical Materials·Jiyoung BaeKenichi Hamada
Nov 2, 2011·Acta Biomaterialia·Shaylin Shadanbaz, George J Dias
Jun 28, 2016·Materials·Vuk Uskoković, Victoria M Wu
Jan 29, 2011·Acta Cirúrgica Brasileira·Taís Somacal Novaes SilvaLuis Alberto Santos
Jul 13, 2017·Advanced Healthcare Materials·Degang YangHao Bai
Jan 1, 2010·Journal of Functional Biomaterials·Sergey V Dorozhkin
Jan 1, 2013·Journal of Functional Biomaterials·Sergey V Dorozhkin
Jan 23, 2018·Bone Research·Hockin Hk XuMark A Reynolds
Oct 6, 2018·Journal of Biomedical Materials Research. Part a·Dhivyaa AnandanAmit Kumar Jaiswal
Jul 7, 2010·Journal of Tissue Engineering and Regenerative Medicine·Liliana OfferReinhard Schnettler
Jul 13, 2019·Journal of Biomedical Materials Research. Part a·Michal DziadekTimothy E L Douglas
Sep 6, 2013·Materials·Sergey V Dorozhkin
Dec 7, 2018·Tissue Engineering. Part C, Methods·Alain HoornaertPierre Layrolle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.